{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:04:34Z","timestamp":1794283474186,"version":"4.9.0"},"reference-count":243,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"crossref","award":["2201110266"],"award-info":[{"award-number":["2201110266"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"crossref","award":["24011102102"],"award-info":[{"award-number":["24011102102"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00708-1","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:36:01Z","timestamp":1748428561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora"],"prefix":"10.1186","volume":"17","author":[{"given":"Christina","family":"Almarmouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed I.","family":"El-Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsul","family":"Qumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merylin","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ghemrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibran Sualeh","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Burucoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalia","family":"Khoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.3390\/jcm10163473","volume":"10","author":"I Mladenova","year":"2021","unstructured":"Mladenova I. Clinical relevance of Helicobacter pylori infection. J Clin Med. 2021;10:3473. https:\/\/doi.org\/10.3390\/jcm10163473.","journal-title":"J Clin Med"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022.","journal-title":"Gastroenterology"},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrgastro.2010.154","volume":"7","author":"Y Yamaoka","year":"2010","unstructured":"Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7:629\u201341. https:\/\/doi.org\/10.1038\/nrgastro.2010.154.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou J-M, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primer. 2023;9:19. https:\/\/doi.org\/10.1038\/s41572-023-00431-8.","journal-title":"Nat Rev Dis Primer"},{"issue":"Suppl 1","key":"708_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12165","volume":"19","author":"LH Eusebi","year":"2014","unstructured":"Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19(Suppl 1):1\u20135. https:\/\/doi.org\/10.1111\/hel.12165.","journal-title":"Helicobacter"},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM. Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence consensus report. Gut. 2017;66:6\u201330. https:\/\/doi.org\/10.1136\/gutjnl-2016-312288.","journal-title":"Gut"},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514\u201333. https:\/\/doi.org\/10.1111\/apt.13497.","journal-title":"Aliment Pharmacol Ther"},{"key":"708_CR8","unstructured":"Moja PL. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017. https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12. Accessed 9 Apri 2025."},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cll.2014.08.008","volume":"34","author":"DE Freedberg","year":"2014","unstructured":"Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014;34:771\u201385. https:\/\/doi.org\/10.1016\/j.cll.2014.08.008.","journal-title":"Clin Lab Med"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/life12122038","volume":"12","author":"LT Roberts","year":"2022","unstructured":"Roberts LT, Issa PP, Sinnathamby ES, Granier M, Mayeux H, Eubanks TN, Malone K, Ahmadzadeh S, Cornett EM, Shekoohi S, Kaye AD. Helicobacter pylori: a review of current treatment options in clinical practice. Life. 2022;12:2038. https:\/\/doi.org\/10.3390\/life12122038.","journal-title":"Life"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3748\/wjg.v20.i6.1450","volume":"20","author":"G Ayala","year":"2014","unstructured":"Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herrera CF, Romero I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol. 2014;20:1450\u201369. https:\/\/doi.org\/10.3748\/wjg.v20.i6.1450.","journal-title":"World J Gastroenterol"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00203-022-03314-w","volume":"204","author":"X Bai","year":"2022","unstructured":"Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol. 2022;204:692. https:\/\/doi.org\/10.1007\/s00203-022-03314-w.","journal-title":"Arch Microbiol"},{"key":"708_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.549084","author":"AB Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz AB, Stepanian J, Trespalacios AA, Vale FF. Bacteriophages of Helicobacter pylori. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.549084.","journal-title":"Front Microbiol"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"2410893","DOI":"10.1002\/advs.202410893","volume":"12","author":"CA Roque-Borda","year":"2025","unstructured":"Roque-Borda CA, Primo LM, Medina-Alarc\u00f3n KP, Campos IC, Nascimento CD, Saraiva MM, Berchieri Junior A, Fusco-Almeida AM, Mendes-Giannini MJ, Perdig\u00e3o J, Pavan FR. Antimicrobial peptides: a promising alternative to conventional antimicrobials for combating polymicrobial biofilms. Adv Sci. 2025;12:2410893.","journal-title":"Adv Sci"},{"issue":"Suppl 1","key":"708_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/hel.12156","volume":"19","author":"MM D\u2019Elios","year":"2014","unstructured":"D\u2019Elios MM, Czinn SJ. Immunity, inflammation, and vaccines for Helicobacter pylori. Helicobacter. 2014;19(Suppl 1):19\u201326. https:\/\/doi.org\/10.1111\/hel.12156.","journal-title":"Helicobacter"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","volume":"136","author":"TL Cover","year":"2009","unstructured":"Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863\u201373. https:\/\/doi.org\/10.1053\/j.gastro.2009.01.073.","journal-title":"Gastroenterology"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00054-05","volume":"19","author":"JG Kusters","year":"2006","unstructured":"Kusters JG, Van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449\u201390. https:\/\/doi.org\/10.1128\/CMR.00054-05.","journal-title":"Clin Microbiol Rev"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.celrep.2016.01.017","volume":"14","author":"S Kienesberger","year":"2016","unstructured":"Kienesberger S, Cox LM, Livanos A, Zhang X-S, Chung J, Perez-Perez GI, Gorkiewicz G, Zechner EL, Blaser MJ. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14:1395\u2013407. https:\/\/doi.org\/10.1016\/j.celrep.2016.01.017.","journal-title":"Cell Rep"},{"key":"708_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, Carneiro F, Machado JC, Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67:226\u201336. https:\/\/doi.org\/10.1136\/gutjnl-2017-314205.","journal-title":"Gut"},{"key":"708_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.631140\/full","author":"TB Devi","year":"2024","unstructured":"Devi TB, et al. Low bifidobacterium abundance in the lower gut microbiota is associated with helicobacter pylori-related gastric ulcer and gastric cancer. Front Microbiol. 2024. https:\/\/doi.org\/10.3389\/fmicb.2021.631140\/full.","journal-title":"Front Microbiol"},{"key":"708_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66128-0","author":"P Palamides","year":"2020","unstructured":"Palamides P, Jolaiya T, Idowu A, Loell E, Onyekwere C, Ugiagbe R, Agbo I, Lesi O, Ndububa D, Adekanle O, Carranza M, Ally R, Njom H, Adeleye IA, Harrison U, Clarke A, Fischer W, Smith S, Haas R. Helicobacter pylori patient isolates from South Africa and Nigeria differ in virulence factor pathogenicity profile and associated gastric disease outcome. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-66128-0.","journal-title":"Sci Rep"},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/microorganisms9122502","volume":"9","author":"YY Cheok","year":"2021","unstructured":"Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An overview of Helicobacter pylori survival tactics in the hostile human stomach environment. Microorganisms. 2021;9:2502. https:\/\/doi.org\/10.3390\/microorganisms9122502.","journal-title":"Microorganisms"},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/toxins13070485","volume":"13","author":"D Doohan","year":"2021","unstructured":"Doohan D, Rezkitha YAA, Waskito LA, Yamaoka Y, Miftahussurur M. Helicobacter pylori BabA\u2013SabA key roles in the adherence phase: the synergic mechanism for successful colonization and disease development. Toxins. 2021;13:485. https:\/\/doi.org\/10.3390\/toxins13070485.","journal-title":"Toxins"},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3018326","volume":"2020","author":"Muzaheed","year":"2020","unstructured":"Muzaheed. Helicobacter pylori oncogenicity: mechanism, prevention, and risk factors. Sci World J. 2020;2020:1\u201310. https:\/\/doi.org\/10.1155\/2020\/3018326.","journal-title":"Sci World J"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.bpg.2014.09.004","volume":"28","author":"RM Ferreira","year":"2014","unstructured":"Ferreira RM, Machado JC, Figueiredo C. Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma. Best Pract Res Clin Gastroenterol. 2014;28:1003\u201315. https:\/\/doi.org\/10.1016\/j.bpg.2014.09.004.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"708_CR26","doi-asserted-by":"publisher","DOI":"10.4172\/jpb.1000409","author":"P Chiranjeevi","year":"2016","unstructured":"Chiranjeevi P, Swargam S, Pradeep N, Kanipakam H, Katari SK, Madhulitha NR. Inhibitor design for VacA toxin of Helicobacter pylori. J Proteom Bioinform. 2016. https:\/\/doi.org\/10.4172\/jpb.1000409.","journal-title":"J Proteom Bioinform"},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1080\/07391102.2018.1526714","volume":"37","author":"C Pasala","year":"2019","unstructured":"Pasala C, Swargam S, Pradeep N, Hema K, Katari SK, Nalamolu RM, Madhulitha NR, Umamaheswari A. Epitope-driven common subunit vaccine design against H. pylori strains. J Biomol Struct Dyn. 2019;37:3740\u201350. https:\/\/doi.org\/10.1080\/07391102.2018.1526714.","journal-title":"J Biomol Struct Dyn"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/antibiotics9060293","volume":"9","author":"E Ierardi","year":"2020","unstructured":"Ierardi E, Losurdo G, Mileti A, Paolillo R, Giorgio F, Principi M, Di Leo A. The puzzle of coccoid forms of Helicobacter pylori: beyond basic science. Antibiotics. 2020;9:293. https:\/\/doi.org\/10.3390\/antibiotics9060293.","journal-title":"Antibiotics"},{"key":"708_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00001-18.10.1128\/mmbr.00001-18","author":"S Hathroubi","year":"2018","unstructured":"Hathroubi S, Servetas SL, Windham I, Merrell DS, Ottemann KM. Helicobacter pylori biofilm formation and its potential role in pathogenesis. Microbiol Mol Biol Rev. 2018. https:\/\/doi.org\/10.1128\/mmbr.00001-18.10.1128\/mmbr.00001-18.","journal-title":"Microbiol Mol Biol Rev"},{"key":"708_CR30","doi-asserted-by":"publisher","first-page":"1243564","DOI":"10.3389\/fchbi.2023.1243564","volume":"2","author":"N Carosella","year":"2023","unstructured":"Carosella N, Brock KP, Zambelli B, Musiani F, Sander C, Ciurli S. Functional contacts for activation of urease from Helicobacter pylori: an integrated approach using evolutionary couplings, in-cell enzymatic assays, and computational docking. Front Chem Biol. 2023;2:1243564. https:\/\/doi.org\/10.3389\/fchbi.2023.1243564.","journal-title":"Front Chem Biol"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2958.1993.tb01220.x","volume":"9","author":"CM Collins","year":"1993","unstructured":"Collins CM, D\u2019Orazio SEF. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol Microbiol. 1993;9:907\u201313. https:\/\/doi.org\/10.1111\/j.1365-2958.1993.tb01220.x.","journal-title":"Mol Microbiol"},{"key":"708_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12638","volume":"24","author":"M Chmiela","year":"2019","unstructured":"Chmiela M, Kupcinskas J. Review: pathogenesis of Helicobacter pylori infection. Helicobacter. 2019;24: e12638. https:\/\/doi.org\/10.1111\/hel.12638.","journal-title":"Helicobacter"},{"key":"708_CR33","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.3390\/jcm11164822","volume":"11","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Okamoto A. Helicobacter pylori infection and chronic immune thrombocytopenia. J Clin Med. 2022;11:4822. https:\/\/doi.org\/10.3390\/jcm11164822.","journal-title":"J Clin Med"},{"key":"708_CR34","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.gastro.2005.03.083","volume":"128","author":"P Farinha","year":"2005","unstructured":"Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128:1579\u2013605. https:\/\/doi.org\/10.1053\/j.gastro.2005.03.083.","journal-title":"Gastroenterology"},{"key":"708_CR35","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3390\/ijms24032895","volume":"24","author":"S Salvatori","year":"2023","unstructured":"Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: pathogenetic mechanisms. Int J Mol Sci. 2023;24:2895. https:\/\/doi.org\/10.3390\/ijms24032895.","journal-title":"Int J Mol Sci"},{"key":"708_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.1.25","author":"P Bauerfeind","year":"1997","unstructured":"Bauerfeind P, Garner R, Dunn BE, Mobley HLT. Synthesis and activity of Helicobacter pyloni urease and catalase at low pH. Gut. 1997. https:\/\/doi.org\/10.1136\/gut.40.1.25.","journal-title":"Gut"},{"key":"708_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004062","volume":"10","author":"JC Rutherford","year":"2014","unstructured":"Rutherford JC. The emerging role of urease as a general microbial virulence factor. PLoS Pathog. 2014;10: e1004062. https:\/\/doi.org\/10.1371\/journal.ppat.1004062.","journal-title":"PLoS Pathog"},{"key":"708_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/inorganics7080104","volume":"7","author":"K Higgins","year":"2019","unstructured":"Higgins K. Nickel metalloregulators and chaperones. Inorganics. 2019;7:104. https:\/\/doi.org\/10.3390\/inorganics7080104.","journal-title":"Inorganics"},{"key":"708_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00094","author":"H De Reuse","year":"2013","unstructured":"De Reuse H, Vinella D, Cavazza C. Common themes and unique proteins for the uptake and trafficking of nickel, a metal essential for the virulence of Helicobacter pylori. Front Cell Infect Microbiol. 2013. https:\/\/doi.org\/10.3389\/fcimb.2013.00094.","journal-title":"Front Cell Infect Microbiol"},{"key":"708_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004472","volume":"10","author":"D Mora","year":"2014","unstructured":"Mora D, Arioli S. Microbial urease in health and disease. PLOS Pathog. 2014;10: e1004472. https:\/\/doi.org\/10.1371\/journal.ppat.1004472.","journal-title":"PLOS Pathog"},{"key":"708_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.ESP-0009-2017","author":"CE Armbruster","year":"2018","unstructured":"Armbruster CE, Mobley HL, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018. https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0009-2017.","journal-title":"EcoSal Plus"},{"key":"708_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0017-2013","author":"JN Schaffer","year":"2015","unstructured":"Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. Microbiol Spectr. 2015. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0017-2013.","journal-title":"Microbiol. Spectr."},{"key":"708_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.991657","volume":"12","author":"A Palusiak","year":"2022","unstructured":"Palusiak A. Proteus mirabilis and Klebsiella pneumoniae as pathogens capable of causing co-infections and exhibiting similarities in their virulence factors. Front Cell Infect Microbiol. 2022;12: 991657. https:\/\/doi.org\/10.3389\/fcimb.2022.991657.","journal-title":"Front Cell Infect Microbiol"},{"key":"708_CR44","volume-title":"StatPearls","author":"S Ehlers","year":"2023","unstructured":"Ehlers S, Merrill SA. Staphylococcus saprophyticus infection. In: Ehlers S, editor. StatPearls. Treasure Island: StatPearls Publishing; 2023."},{"key":"708_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12884-020-03147-9","volume":"20","author":"A Peretz","year":"2020","unstructured":"Peretz A, Tameri O, Azrad M, Barak S, Perlitz Y, Dahoud WA, Ben-Ami M, Kushnir A. Mycoplasma and ureaplasma carriage in pregnant women: the prevalence of transmission from mother to newborn. BMC Pregn Childb. 2020;20:456. https:\/\/doi.org\/10.1186\/s12884-020-03147-9.","journal-title":"BMC Pregn Childb"},{"key":"708_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062990","volume":"12","author":"ME Jonduo","year":"2022","unstructured":"Jonduo ME, Vallely LM, Wand H, Sweeney EL, Egli-Gany D, Kaldor J, Vallely AJ, Low N. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a systematic review and meta-analysis. BMJ Open. 2022;12: e062990. https:\/\/doi.org\/10.1136\/bmjopen-2022-062990.","journal-title":"BMJ Open"},{"key":"708_CR47","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1021\/ct5000023","volume":"10","author":"MS Minkara","year":"2014","unstructured":"Minkara MS, Ucisik MN, Weaver MN, Merz KM Jr. Dynamics study of Helicobacter pylori urease. J Chem Theory Comput. 2014;10:1852\u201362. https:\/\/doi.org\/10.1021\/ct5000023.","journal-title":"J Chem Theory Comput"},{"key":"708_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/364891","volume":"2010","author":"H Carlsson","year":"2010","unstructured":"Carlsson H, Nordlander E. Computational modeling of the mechanism of urease. Bioinorg Chem Appl. 2010;2010:1\u20138. https:\/\/doi.org\/10.1155\/2010\/364891.","journal-title":"Bioinorg Chem Appl"},{"key":"708_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41467-020-20485-6","volume":"12","author":"ES Cunha","year":"2021","unstructured":"Cunha ES, Chen X, Sanz-Gaitero M, Mills DJ, Luecke H. Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 2.0 \u00c5 resolution. Nat Commun. 2021;12:230. https:\/\/doi.org\/10.1038\/s41467-020-20485-6.","journal-title":"Nat Commun"},{"key":"708_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/88563","volume":"8","author":"NC Ha","year":"2001","unstructured":"Ha NC, Oh ST, Sung JY, Cha KA, Lee MH, Oh BH. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol. 2001;8:505.","journal-title":"Nat Struct Biol"},{"key":"708_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00775-020-01808-w","volume":"25","author":"L Mazzei","year":"2020","unstructured":"Mazzei L, Musiani F, Ciurli S. The structure-based reaction mechanism of urease, a nickel dependent enzyme: tale of a long debate. JBIC J Biol Inorg Chem. 2020;25:829\u201345. https:\/\/doi.org\/10.1007\/s00775-020-01808-w.","journal-title":"JBIC J Biol Inorg Chem"},{"key":"708_CR52","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1021\/ar200041k","volume":"44","author":"B Zambelli","year":"2011","unstructured":"Zambelli B, Musiani F, Benini S, Ciurli S. Chemistry of Ni 2+ in urease: sensing, trafficking, and catalysis. Acc Chem Res. 2011;44:520\u201330. https:\/\/doi.org\/10.1021\/ar200041k.","journal-title":"Acc Chem Res"},{"key":"708_CR53","doi-asserted-by":"publisher","first-page":"10828","DOI":"10.1021\/ja0525399","volume":"127","author":"BP Callahan","year":"2005","unstructured":"Callahan BP, Yuan Y, Wolfenden R. The burden borne by urease. J Am Chem Soc. 2005;127:10828\u20139. https:\/\/doi.org\/10.1021\/ja0525399.","journal-title":"J Am Chem Soc"},{"key":"708_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2024.2423004","author":"\u00d6 G\u00fczel-Akdemir","year":"2024","unstructured":"G\u00fczel-Akdemir \u00d6, Akdemir A. Urease inhibitors for the treatment of H. pylori. Expert Opin Ther Pat. 2024. https:\/\/doi.org\/10.1080\/13543776.2024.2423004.","journal-title":"Expert Opin Ther Pat"},{"key":"708_CR55","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/polym12112713","volume":"12","author":"HL Barazorda-Ccahuana","year":"2020","unstructured":"Barazorda-Ccahuana HL, G\u00f3mez B, Mas F, Madurga S. Effect of pH on the supramolecular structure of Helicobacter pylori urease by molecular dynamics simulations. Polymers. 2020;12:2713. https:\/\/doi.org\/10.3390\/polym12112713.","journal-title":"Polymers"},{"key":"708_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0966-842X(01)02287-9","volume":"10","author":"K Stingl","year":"2002","unstructured":"Stingl K, Altendorf K, Bakker EP. Acid survival of Helicobacter pylori: how does urease activity trigger cytoplasmic pH homeostasis? Trends Microbiol. 2002;10:70\u20134. https:\/\/doi.org\/10.1016\/S0966-842X(01)02287-9.","journal-title":"Trends Microbiol"},{"key":"708_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1126\/science.287.5452.482","volume":"287","author":"DL Weeks","year":"2000","unstructured":"Weeks DL, Eskandari S, Scott DR, Sachs G. A H + -gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science. 2000;287:482\u20135. https:\/\/doi.org\/10.1126\/science.287.5452.482.","journal-title":"Science"},{"key":"708_CR58","doi-asserted-by":"publisher","first-page":"eaav8423","DOI":"10.1126\/sciadv.aav8423","volume":"5","author":"Y Cui","year":"2019","unstructured":"Cui Y, Zhou K, Strugatsky D, Wen Y, Sachs G, Zhou ZH, Munson K. pH-dependent gating mechanism of the Helicobacter pylori urea channel revealed by cryo-EM. Sci Adv. 2019;5:eaav8423. https:\/\/doi.org\/10.1126\/sciadv.aav8423.","journal-title":"Sci Adv"},{"key":"708_CR59","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/mr.59.3.451-480.1995","volume":"59","author":"HL Mobley","year":"1995","unstructured":"Mobley HL, Island MD, Hausinger RP. Molecular biology of microbial ureases. Microbiol Rev. 1995;59:451.","journal-title":"Microbiol Rev"},{"key":"708_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0882-4010(91)90062-F","volume":"10","author":"DJ Evans","year":"1991","unstructured":"Evans DJ, Evans DG, Kirkpatrick SS, Graham DY. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathog. 1991;10:15\u201326. https:\/\/doi.org\/10.1016\/0882-4010(91)90062-F.","journal-title":"Microb Pathog"},{"key":"708_CR61","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2001.02689.x","author":"S Bury-Mon\u00e9","year":"2001","unstructured":"Bury-Mon\u00e9 S, Skouloubris S, Labigne A, De Reuse H. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol Microbiol. 2001. https:\/\/doi.org\/10.1046\/j.1365-2958.2001.02689.x.","journal-title":"Mol Microbiol"},{"key":"708_CR62","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/IAI.68.2.470-477.2000","volume":"68","author":"DR Scott","year":"2000","unstructured":"Scott DR, Marcus EA, Weeks DL, Lee A, Melchers K, Sachs G. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease. Infect Immun. 2000;68:470\u20137. https:\/\/doi.org\/10.1128\/IAI.68.2.470-477.2000.","journal-title":"Infect Immun"},{"key":"708_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00232-006-0867-7","volume":"212","author":"G Sachs","year":"2006","unstructured":"Sachs G, Kraut JA, Wen Y, Feng J, Scott DR. Urea transport in bacteria: acid acclimation by gastric Helicobacter spp. J Membr Biol. 2006;212:71\u201382. https:\/\/doi.org\/10.1007\/s00232-006-0867-7.","journal-title":"J Membr Biol"},{"key":"708_CR64","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.3748\/wjg.v19.i45.8211","volume":"19","author":"R-G Ge","year":"2013","unstructured":"Ge R-G. Nickel trafficking system responsible for urease maturation in Helicobacter pylori. World J Gastroenterol. 2013;19:8211. https:\/\/doi.org\/10.3748\/wjg.v19.i45.8211.","journal-title":"World J Gastroenterol"},{"key":"708_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2958.1995.tb02395.x","volume":"16","author":"HLT Mobley","year":"1995","unstructured":"Mobley HLT, Garner RM, Bauerfeind P. Helicobacter pylori nickel-transport gene nixA\u202f: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol. 1995;16:97\u2013109. https:\/\/doi.org\/10.1111\/j.1365-2958.1995.tb02395.x.","journal-title":"Mol Microbiol"},{"key":"708_CR66","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1128\/IAI.70.2.685-691.2002","volume":"70","author":"KJ Nolan","year":"2002","unstructured":"Nolan KJ, McGee DJ, Mitchell HM, Kolesnikow T, Harro JM, O\u2019Rourke J, Wilson JE, Danon SJ, Moss ND, Mobley HLT, Lee A. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun. 2002;70:685\u201391. https:\/\/doi.org\/10.1128\/IAI.70.2.685-691.2002.","journal-title":"Infect Immun"},{"key":"708_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006018","volume":"12","author":"F Fischer","year":"2016","unstructured":"Fischer F, Robbe-Saule M, Turlin E, Mancuso F, Michel V, Richaud P, Veyrier FJ, De Reuse H, Vinella D. Characterization in Helicobacter pylori of a nickel transporter essential for colonization that was acquired during evolution by gastric helicobacter species. PLOS Pathog. 2016;12: e1006018. https:\/\/doi.org\/10.1371\/journal.ppat.1006018.","journal-title":"PLOS Pathog"},{"key":"708_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2022.105298","volume":"101","author":"U Shankar","year":"2022","unstructured":"Shankar U, Mishra SK, Jain N, Tawani A, Yadav P, Kumar A. Ni+2 permease system of Helicobacter pylori contains highly conserved G-quadruplex motifs. Infect Genet Evol. 2022;101: 105298. https:\/\/doi.org\/10.1016\/j.meegid.2022.105298.","journal-title":"Infect Genet Evol"},{"key":"708_CR69","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1074\/jbc.M113.502781","volume":"289","author":"AM Sydor","year":"2014","unstructured":"Sydor AM, Lebrette H, Ariyakumaran R, Cavazza C, Zamble DB. Relationship between Ni(II) and Zn(II) coordination and nucleotide binding by the Helicobacter pylori [NiFe]-hydrogenase and urease maturation factor HypB. J Biol Chem. 2014;289:3828\u201341. https:\/\/doi.org\/10.1074\/jbc.M113.502781.","journal-title":"J Biol Chem"},{"key":"708_CR70","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00775-013-1002-8","volume":"18","author":"F Biagi","year":"2013","unstructured":"Biagi F, Musiani F, Ciurli S. Structure of the UreD\u2013UreF\u2013UreG\u2013UreE complex in Helicobacter pylori: a model study. JBIC J Biol Inorg Chem. 2013;18:571\u20137. https:\/\/doi.org\/10.1007\/s00775-013-1002-8.","journal-title":"JBIC J Biol Inorg Chem"},{"key":"708_CR71","doi-asserted-by":"publisher","first-page":"43241","DOI":"10.1074\/jbc.M111.296830","volume":"286","author":"YH Fong","year":"2011","unstructured":"Fong YH, Wong HC, Chuck CP, Chen YW, Sun H, Wong K-B. Assembly of preactivation complex for urease maturation in Helicobacter pylori. J Biol Chem. 2011;286:43241\u20139. https:\/\/doi.org\/10.1074\/jbc.M111.296830.","journal-title":"J Biol Chem"},{"key":"708_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001678","volume":"11","author":"YH Fong","year":"2013","unstructured":"Fong YH, Wong HC, Yuen MH, Lau PH, Chen YW, Wong K-B. Structure of UreG\/UreF\/UreH complex reveals how urease accessory proteins facilitate maturation of Helicobacter pylori urease. PLoS Biol. 2013;11: e1001678. https:\/\/doi.org\/10.1371\/journal.pbio.1001678.","journal-title":"PLoS Biol"},{"key":"708_CR73","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00775-013-1068-3","volume":"19","author":"B Zambelli","year":"2014","unstructured":"Zambelli B, Berardi A, Martin-Diaconescu V, Mazzei L, Musiani F, Maroney MJ, Ciurli S. Nickel binding properties of Helicobacter pylori UreF, an accessory protein in the nickel-based activation of urease. JBIC J Biol Inorg Chem. 2014;19:319\u201334. https:\/\/doi.org\/10.1007\/s00775-013-1068-3.","journal-title":"JBIC J Biol Inorg Chem"},{"key":"708_CR74","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/biom10071062","volume":"10","author":"A Pierro","year":"2020","unstructured":"Pierro A, Etienne E, Gerbaud G, Guigliarelli B, Ciurli S, Belle V, Zambelli B, Mileo E. Nickel and GTP modulate Helicobacter pylori UreG structural flexibility. Biomolecules. 2020;10:1062. https:\/\/doi.org\/10.3390\/biom10071062.","journal-title":"Biomolecules"},{"key":"708_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003887","volume":"16","author":"X Yang","year":"2018","unstructured":"Yang X, Koohi-Moghadam M, Wang R, Chang Y-Y, Woo PCY, Wang J, Li H, Sun H. Metallochaperone UreG serves as a new target for design of urease inhibitor: a novel strategy for development of antimicrobials. PLOS Biol. 2018;16: e2003887. https:\/\/doi.org\/10.1371\/journal.pbio.2003887.","journal-title":"PLOS Biol"},{"key":"708_CR76","doi-asserted-by":"publisher","first-page":"G96","DOI":"10.1152\/ajpgi.00160.2002","volume":"284","author":"P Voland","year":"2003","unstructured":"Voland P, Weeks DL, Marcus EA, Prinz C, Sachs G, Scott D. Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster. Am J Physiol Gastrointest Liver Physiol. 2003;284:G96\u2013106. https:\/\/doi.org\/10.1152\/ajpgi.00160.2002.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"708_CR77","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/prot.22802","volume":"78","author":"R Lam","year":"2010","unstructured":"Lam R, Romanov V, Johns K, Battaile KP, Wu-Brown J, Guthrie JL, Hausinger RP, Pai EF, Chirgadze NY. Crystal structure of a truncated urease accessory protein UreF from Helicobacter pylori. Proteins Struct Funct Bioinform. 2010;78:2839\u201348. https:\/\/doi.org\/10.1002\/prot.22802.","journal-title":"Proteins Struct Funct Bioinform"},{"key":"708_CR78","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1074\/jbc.M114.632364","volume":"290","author":"X Yang","year":"2015","unstructured":"Yang X, Li H, Lai T-P, Sun H. UreE-UreG complex facilitates nickel transfer and preactivates GTPase of UreG in Helicobacter pylori. J Biol Chem. 2015;290:12474\u201385. https:\/\/doi.org\/10.1074\/jbc.M114.632364.","journal-title":"J Biol Chem"},{"key":"708_CR79","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/acs.jctc.7b00042","volume":"13","author":"F Musiani","year":"2017","unstructured":"Musiani F, Gioia D, Masetti M, Falchi F, Cavalli A, Recanatini M, Ciurli S. Protein tunnels: the case of urease accessory proteins. J Chem Theory Comput. 2017;13:2322\u201331. https:\/\/doi.org\/10.1021\/acs.jctc.7b00042.","journal-title":"J Chem Theory Comput"},{"key":"708_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.790994","volume":"9","author":"H Yang","year":"2022","unstructured":"Yang H, Huang X, Zhang X, Zhang X, Xu X, She F, Wen Y. AI-2 induces urease expression through downregulation of orphan response regulator HP1021 in Helicobacter pylori. Front Med. 2022;9: 790994. https:\/\/doi.org\/10.3389\/fmed.2022.790994.","journal-title":"Front Med"},{"key":"708_CR81","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semcancer.2021.04.009","volume":"76","author":"MJ Maroney","year":"2021","unstructured":"Maroney MJ, Ciurli S. Nickel as a virulence factor in the Class I bacterial carcinogen, Helicobacter pylori. Semin Cancer Biol. 2021;76:143\u201355. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.009.","journal-title":"Semin Cancer Biol"},{"key":"708_CR82","doi-asserted-by":"publisher","first-page":"13210","DOI":"10.3390\/ijms222413210","volume":"22","author":"D Witkowska","year":"2021","unstructured":"Witkowska D, Szebesczyk A, W\u0105t\u0142y J, Braczkowski M, Rowi\u0144ska-\u017byrek M. A comparative study on nickel binding to Hpn-like polypeptides from two Helicobacter pylori strains. Int J Mol Sci. 2021;22:13210. https:\/\/doi.org\/10.3390\/ijms222413210.","journal-title":"Int J Mol Sci"},{"key":"708_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/14756366.2014.910202","volume":"30","author":"C Capasso","year":"2015","unstructured":"Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem. 2015;30:325\u201332. https:\/\/doi.org\/10.3109\/14756366.2014.910202.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"708_CR84","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.2174\/0929867321666141012174921","volume":"22","author":"C Capasso","year":"2015","unstructured":"Capasso C, Supuran CT. An overview of the selectivity and efficiency of the bacterial carbonic anhydrase inhibitors. Curr Med Chem. 2015;22:2130\u20139. https:\/\/doi.org\/10.2174\/0929867321666141012174921.","journal-title":"Curr Med Chem"},{"key":"708_CR85","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1128\/IAI.00993-07","volume":"76","author":"S Bury-Mon\u00e9","year":"2008","unstructured":"Bury-Mon\u00e9 S, Mendz GL, Ball GE, Thibonnier M, Stingl K, Ecobichon C, Av\u00e9 P, Huerre M, Labigne A, Thiberge J-M, De Reuse H. Roles of \u03b1 and \u03b2 carbonic anhydrases of Helicobacter pylori in the urease-dependent response to acidity and in colonization of the murine gastric mucosa. Infect Immun. 2008;76:497\u2013509. https:\/\/doi.org\/10.1128\/IAI.00993-07.","journal-title":"Infect Immun"},{"key":"708_CR86","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.12688\/f1000research.8598.1","volume":"5","author":"DR Scott","year":"2016","unstructured":"Scott DR, Sachs G, Marcus EA. The role of acid inhibition in Helicobacter pylori eradication. Research. 2016;5:1747. https:\/\/doi.org\/10.12688\/f1000research.8598.1.","journal-title":"Research"},{"key":"708_CR87","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1128\/JB.187.2.729-738.2005","volume":"187","author":"EA Marcus","year":"2005","unstructured":"Marcus EA, Moshfegh AP, Sachs G, Scott DR. The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J Bacteriol. 2005;187:729\u201338. https:\/\/doi.org\/10.1128\/JB.187.2.729-738.2005.","journal-title":"J Bacteriol"},{"key":"708_CR88","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12876-023-02872-7","volume":"23","author":"S Han","year":"2023","unstructured":"Han S, Deng Z, Cheung K, Lyu T, Chan P, Li Y, Ni L, Luo X, Li K. Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol. BMC Gastroenterol. 2023;23:231. https:\/\/doi.org\/10.1186\/s12876-023-02872-7.","journal-title":"BMC Gastroenterol"},{"key":"708_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40364-017-0103-x","volume":"5","author":"C-C Huang","year":"2017","unstructured":"Huang C-C, Tsai K-W, Tsai T-J, Hsu P-I. Update on the first-line treatment for Helicobacter pylori infection\u2014a continuing challenge from an old enemy. Biomark Res. 2017;5:23. https:\/\/doi.org\/10.1186\/s40364-017-0103-x.","journal-title":"Biomark Res"},{"key":"708_CR90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.14309\/ajg.0000000000002045","volume":"118","author":"F M\u00e9graud","year":"2023","unstructured":"M\u00e9graud F, Graham DY, Howden CW, Trevino E, Weissfeld A, Hunt B, Smith N, Leifke E, Chey WD. Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe. Am J Gastroenterol. 2023;118:269. https:\/\/doi.org\/10.14309\/ajg.0000000000002045.","journal-title":"Am J Gastroenterol"},{"key":"708_CR91","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0140-6736(16)31409-X","volume":"388","author":"J-M Liou","year":"2016","unstructured":"Liou J-M, Fang Y-J, Chen C-C, Bair M-J, Chang C-Y, Lee Y-C, Chen M-J, Chen C-C, Tseng C-H, Hsu Y-C, Lee J-Y, Yang T-H, Luo J-C, Chang C-C, Chen C-Y, Chen P-Y, Shun C-T, Hsu W-F, Hu W-H, Chen Y-N, Sheu B-S, Lin J-T, Wu J-Y, El-Omar EM, Wu M-S. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2016;388:2355\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(16)31409-X.","journal-title":"Lancet"},{"key":"708_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.771876","author":"M Niu","year":"2022","unstructured":"Niu M, Zhou Y, Xie Y, Li X, Tian Y, Yao L, Li X, Gao H, Bai F. Comparison of the dual therapy of ilaprazole-amoxicillin and the bismuth quadruple therapy of ilaprazole\u2013amoxicillin\u2013furazolidone\u2013bismuth glycyrrhizinate for eradication of Helicobacter pylori. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.771876.","journal-title":"Front Pharmacol"},{"key":"708_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1153269","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhao M, Fu X. Gastric microbiota dysbiosis and Helicobacter pylori infection. Front Microbiol. 2023. https:\/\/doi.org\/10.3389\/fmicb.2023.1153269.","journal-title":"Front Microbiol"},{"key":"708_CR94","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/microorganisms12020319","volume":"12","author":"S Abdulkhakov","year":"2024","unstructured":"Abdulkhakov S, Markelova M, Safina D, Siniagina M, Khusnutdinova D, Abdulkhakov R, Grigoryeva T. Butyric acid supplementation reduces changes in the taxonomic and functional composition of gut microbiota caused by H. pylori eradication therapy. Microorganisms. 2024;12:319. https:\/\/doi.org\/10.3390\/microorganisms12020319.","journal-title":"Microorganisms"},{"key":"708_CR95","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12866-021-02315-x","volume":"21","author":"SZ Bakhti","year":"2021","unstructured":"Bakhti SZ, Latifi-Navid S. Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis. BMC Microbiol. 2021;21:258. https:\/\/doi.org\/10.1186\/s12866-021-02315-x.","journal-title":"BMC Microbiol"},{"key":"708_CR96","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.3390\/diagnostics13182944","volume":"13","author":"V Jearth","year":"2023","unstructured":"Jearth V, Rath MM, Chatterjee A, Kale A, Panigrahi MK. Drug-resistant Helicobacter pylori: diagnosis and evidence-based approach. Diagnostics. 2023;13:2944. https:\/\/doi.org\/10.3390\/diagnostics13182944.","journal-title":"Diagnostics"},{"key":"708_CR97","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12876-019-1062-5","volume":"19","author":"JW Seo","year":"2019","unstructured":"Seo JW, Park JY, Shin T-S, Kim JG. The analysis of virulence factors and antibiotic resistance between Helicobacter pylori strains isolated from gastric antrum and body. BMC Gastroenterol. 2019;19:140. https:\/\/doi.org\/10.1186\/s12876-019-1062-5.","journal-title":"BMC Gastroenterol"},{"key":"708_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1207878","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gu H, Shi Z, Chen W, Li A, Ye W, Zhang C, Yuan H, Zhao M. High prevalence of Helicobacter pylori mixed infections identified by multilocus sequence typing in Ningbo, China. Front Microbiol. 2023. https:\/\/doi.org\/10.3389\/fmicb.2023.1207878.","journal-title":"Front Microbiol"},{"key":"708_CR99","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance\u2014from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021;18:613\u201329. https:\/\/doi.org\/10.1038\/s41575-021-00449-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"708_CR100","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2295973","author":"GS Asadi","year":"2023","unstructured":"Asadi GS, Abdizadeh R, Abdizadeh T. Investigation of a set of flavonoid compounds as Helicobacter pylori urease inhibitors: insights from in silico studies. J Biomol Struct Dyn. 2023. https:\/\/doi.org\/10.1080\/07391102.2023.2295973.","journal-title":"J Biomol Struct Dyn"},{"key":"708_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/248585","volume":"2013","author":"J-C Yang","year":"2013","unstructured":"Yang J-C, Yang H-C, Shun C-T, Wang T-H, Chien C-T, Kao JY. Catechins and sialic acid attenuate Helicobacter pylori\u2014triggered Epithelial caspase-1 activity and eradicate Helicobacter pylori infection. Evid Based Complement Alternat Med. 2013;2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/248585.","journal-title":"Evid Based Complement Alternat Med"},{"key":"708_CR102","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3945\/jn.108.090985","volume":"138","author":"J-C Yang","year":"2008","unstructured":"Yang J-C, Shun C-T, Chien C-T, Wang T-H. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB\/c mice. J Nutr. 2008;138:2084\u201390. https:\/\/doi.org\/10.3945\/jn.108.090985.","journal-title":"J Nutr"},{"key":"708_CR103","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3390\/plants12244083","volume":"12","author":"T-Y Kim","year":"2023","unstructured":"Kim T-Y, Lee BS, Jo B-G, Heo SP, Keem M-J, Kwon T-H, Kim S-N, Kim KH, Yang MH. 3\u2034-O-foliamenthoyl-rutin, a new flavonoid glycoside from the roots of nymphoides peltata. Plants. 2023;12:4083. https:\/\/doi.org\/10.3390\/plants12244083.","journal-title":"Plants"},{"key":"708_CR104","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.3390\/molecules28052138","volume":"28","author":"I Nikoli\u0107","year":"2023","unstructured":"Nikoli\u0107 I, Chua EG, Tay ACY, Kostre\u0161evi\u0107 A, Pavlovi\u0107 B, Jon\u010di\u0107 Savi\u0107 K. Savory, oregano and thyme essential oil mixture (HerbELICO\u00ae) counteracts Helicobacter pylori. Molecules. 2023;28:2138. https:\/\/doi.org\/10.3390\/molecules28052138.","journal-title":"Molecules"},{"key":"708_CR105","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.3390\/molecules26113193","volume":"26","author":"BS Zhumakanova","year":"2021","unstructured":"Zhumakanova BS, Korona-G\u0142owniak I, Skalicka-Wo\u017aniak K, Ludwiczuk A, Baj T, Wojtanowski KK, J\u00f3zefczyk A, Zhaparkulova KA, Sakipova ZB, Malm A. Phytochemical fingerprinting and in vitro antimicrobial and antioxidant activity of the aerial parts of Thymus marschallianus Willd. and Thymus seravschanicus Klokov growing widely in Southern Kazakhstan. Molecules. 2021;26:3193. https:\/\/doi.org\/10.3390\/molecules26113193.","journal-title":"Molecules"},{"key":"708_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.1996.tb03272.x","author":"M Tabak","year":"1996","unstructured":"Tabak M, Armon R, Potasman I, Neeman I. In vitro inhibition of Helicobacter pylori by extracts of thyme. J Appl Bacteriol. 1996. https:\/\/doi.org\/10.1111\/j.1365-2672.1996.tb03272.x.","journal-title":"J Appl Bacteriol"},{"key":"708_CR107","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1476-0711-4-20","volume":"4","author":"SM Ali","year":"2005","unstructured":"Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, Rao LV, Habibullah CM, Sechi LA, Ahmed N. Antimicrobial activities of eugenol and cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob. 2005;4:20. https:\/\/doi.org\/10.1186\/1476-0711-4-20.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"708_CR108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10020-023-00641-6","volume":"29","author":"U Khan","year":"2023","unstructured":"Khan U, Karmakar BC, Basak P, Paul S, Gope A, Sarkar D, Mukhopadhyay AK, Dutta S, Bhattacharya S. Glycyrrhizin, an inhibitor of HMGB1 induces autolysosomal degradation function and inhibits Helicobacter pylori infection. Mol Med. 2023;29:51. https:\/\/doi.org\/10.1186\/s10020-023-00641-6.","journal-title":"Mol Med"},{"key":"708_CR109","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00284-002-3956-6","volume":"47","author":"Y Yamamoto","year":"2003","unstructured":"Yamamoto Y, Yanagawa Y, Hara Y, Shimamura T. A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro. Curr Microbiol. 2003;47:244\u20139. https:\/\/doi.org\/10.1007\/s00284-002-3956-6.","journal-title":"Curr Microbiol"},{"key":"708_CR110","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1021\/acsomega.0c04763","volume":"6","author":"R Raj","year":"2021","unstructured":"Raj R, Agarwal N, Raghavan S, Chakraborti T, Poluri KM, Pande G, Kumar D. Epigallocatechin gallate with potent anti-Helicobacter pylori activity binds efficiently to its histone-like DNA binding protein. ACS Omega. 2021;6:3548\u201370. https:\/\/doi.org\/10.1021\/acsomega.0c04763.","journal-title":"ACS Omega"},{"key":"708_CR111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s43088-023-00417-1","volume":"12","author":"TA Addissouky","year":"2023","unstructured":"Addissouky TA, Wang Y, El Sayed IET, Baz AE, Ali MMA, Khalil AA. Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches. Beni-Suef Univ J Basic Appl Sci. 2023;12:80. https:\/\/doi.org\/10.1186\/s43088-023-00417-1.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"708_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2020.e00470","volume":"26","author":"DA Baker","year":"2020","unstructured":"Baker DA. Plants against Helicobacter pylori to combat resistance: an ethnopharmacological review. Biotechnol Rep. 2020;26: e00470. https:\/\/doi.org\/10.1016\/j.btre.2020.e00470.","journal-title":"Biotechnol Rep"},{"key":"708_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1040841X.2021.1975643","volume":"48","author":"C Sousa","year":"2021","unstructured":"Sousa C, Ferreira R, Azevedo N, Oleastro M, Azeredo J, Figueiredo C, Melo L. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol. 2021;48:1\u201321. https:\/\/doi.org\/10.1080\/1040841X.2021.1975643.","journal-title":"Crit Rev Microbiol"},{"key":"708_CR114","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12866-022-02701-z","volume":"22","author":"TTD Thuy","year":"2022","unstructured":"Thuy TTD, Kuo P-Y, Lin S-M, Kao C-Y. Anti-Helicobacter pylori activity of potential probiotic Lactiplantibacillus pentosus SLC13. BMC Microbiol. 2022;22:277. https:\/\/doi.org\/10.1186\/s12866-022-02701-z.","journal-title":"BMC Microbiol"},{"key":"708_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8607671","volume":"2022","author":"C He","year":"2022","unstructured":"He C, Kong F, Chai X, Zou C, Zhu X, Zhao D. Effect of probiotic-assisted eradication of cagA+\/vacA s1m1 Helicobacter pylori on intestinal flora. BioMed Res Int. 2022;2022:1\u201312. https:\/\/doi.org\/10.1155\/2022\/8607671.","journal-title":"BioMed Res Int"},{"key":"708_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300241","author":"S Wu","year":"2023","unstructured":"Wu S, Xu Y, Chen Z, Chen Y, Wei F, Xia C, Zhou Q, Li P, Gu Q. Lactiplantibacillus plantarum ZJ316 reduces Helicobacter pylori adhesion and inflammation by inhibiting the expression of adhesin and urease genes. Mol Nutr Food Res. 2023. https:\/\/doi.org\/10.1002\/mnfr.202300241.","journal-title":"Mol Nutr Food Res"},{"key":"708_CR117","doi-asserted-by":"publisher","first-page":"175628482311916","DOI":"10.1177\/17562848231191669","volume":"16","author":"T Kakiuchi","year":"2023","unstructured":"Kakiuchi T. Adequate amounts of probiotics increase the success rate of Helicobacter pylori eradication therapy in children. Ther Adv Gastroenterol. 2023;16:17562848231191668. https:\/\/doi.org\/10.1177\/17562848231191669.","journal-title":"Ther Adv Gastroenterol"},{"key":"708_CR118","doi-asserted-by":"publisher","DOI":"10.23736\/S1121-421X.19.02651-5","author":"F Di Pierro","year":"2020","unstructured":"Di Pierro F, Bertuccioli A, Saponara M, Ivaldi L. Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication. Miner Gastroenterol Dietol. 2020. https:\/\/doi.org\/10.23736\/S1121-421X.19.02651-5.","journal-title":"Miner Gastroenterol Dietol"},{"key":"708_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.13138","author":"Y Wu","year":"2022","unstructured":"Wu Y, Dong XY, Zhou XZ, Li ZS, Du YQ. Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication. J Dig Dis. 2022. https:\/\/doi.org\/10.1111\/1751-2980.13138.","journal-title":"J Dig Dis"},{"key":"708_CR120","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajg.2022.10.004","volume":"24","author":"M Mohtasham","year":"2023","unstructured":"Mohtasham M, Joukar F, Maroufizadeh S, Mojtahedi K, Asgharnezhad M, Mansour-Ghanaei F. Lactobacillus ruteri compared with placebo as an adjuvant in quadruple therapy for Helicobacter pylori eradication: a randomized, double-blind, controlled trial, Arab. J Gastroenterol. 2023;24:40\u20134. https:\/\/doi.org\/10.1016\/j.ajg.2022.10.004.","journal-title":"J Gastroenterol"},{"key":"708_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1120789","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang X, Cao X-Y, Zhu H-L, Miao L. Comparative effectiveness of different probiotics supplements for triple Helicobacter pylori eradication: a network meta-analysis. Front Cell Infect Microbiol. 2023. https:\/\/doi.org\/10.3389\/fcimb.2023.1120789.","journal-title":"Front Cell Infect Microbiol"},{"key":"708_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223309","volume":"14","author":"M Yu","year":"2019","unstructured":"Yu M, Zhang R, Ni P, Chen S, Duan G. Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: a meta-analysis of randomized controlled trials. PLoS ONE. 2019;14: e0223309. https:\/\/doi.org\/10.1371\/journal.pone.0223309.","journal-title":"PLoS ONE"},{"key":"708_CR123","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.3768","volume":"26","author":"K Namkin","year":"2016","unstructured":"Namkin K, Zardast M, Basirinejad F. Saccharomyces boulardii in Helicobacter pylori eradication in children: a randomized trial from Iran. Iran J Pediatr. 2016;26: e3768. https:\/\/doi.org\/10.5812\/ijp.3768.","journal-title":"Iran J Pediatr"},{"key":"708_CR124","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1677464","author":"T Safarov","year":"2019","unstructured":"Safarov T, Kiran B, Bagirova M, Allahverdiyev AM, Abamor ES. An overview of nanotechnology-based treatment approaches against Helicobacter pylori. Expert Rev Anti-infect Ther. 2019. https:\/\/doi.org\/10.1080\/14787210.2019.1677464.","journal-title":"Expert Rev Anti-infect Ther"},{"key":"708_CR125","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jare.2021.11.008","volume":"39","author":"M Haider","year":"2022","unstructured":"Haider M, Zaki KZ, El Hamshary MR, Hussain Z, Orive G, Ibrahim HO. Polymeric nanocarriers: a promising tool for early diagnosis and efficient treatment of colorectal cancer. J Adv Res. 2022;39:237\u201355. https:\/\/doi.org\/10.1016\/j.jare.2021.11.008.","journal-title":"J Adv Res"},{"key":"708_CR126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/B978-0-323-90750-7.00001-6","volume-title":"Nanotechnology and human health","author":"DP Gond","year":"2023","unstructured":"Gond DP, Srivastava A, Sharma A, Mrinalini K. Chapter 2-current and future prospects of nanoparticles to combat bacterial infections. In: Yadav MK, Babu PJ, Song JJ, Kharat AS, editors. Nanotechnology and human health. Amsterdam: Elsevier; 2023. p. 49\u201373. https:\/\/doi.org\/10.1016\/B978-0-323-90750-7.00001-6."},{"key":"708_CR127","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1039\/D0RA09941D","volume":"11","author":"C Vanlalveni","year":"2021","unstructured":"Vanlalveni C, Lallianrawna S, Biswas A, Selvaraj M, Changmai B, Rokhum SL. Green synthesis of silver nanoparticles using plant extracts and their antimicrobial activities: a review of recent literature. RSC Adv. 2021;11:2804\u201337. https:\/\/doi.org\/10.1039\/D0RA09941D.","journal-title":"RSC Adv"},{"key":"708_CR128","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jobm.201900537","volume":"60","author":"V Gopalakrishnan","year":"2020","unstructured":"Gopalakrishnan V, Masanam E, Ramkumar VS, Baskaraligam V, Selvaraj G. Influence of N-acylhomoserine lactonase silver nanoparticles on the quorum sensing system of Helicobacter pylori: a potential strategy to combat biofilm formation. J Basic Microbiol. 2020;60:207\u201315. https:\/\/doi.org\/10.1002\/jobm.201900537.","journal-title":"J Basic Microbiol"},{"key":"708_CR129","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2147\/IJN.S405052","volume":"31","author":"X Yin","year":"2023","unstructured":"Yin X, Lai Y, Du Y, Zhang T, Gao J, Li Z. Metal-based nanoparticles: a prospective strategy for Helicobacter pylori treatment. Int J Nanomed. 2023;31:2413\u201329.","journal-title":"Int J Nanomed"},{"key":"708_CR130","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/pharmaceutics14071463","volume":"14","author":"R Pop","year":"2022","unstructured":"Pop R, T\u0103b\u0103ran A-F, Ungur AP, Negoescu A, C\u0103toi C. Helicobacter pylori-induced gastric infections: from pathogenesis to novel therapeutic approaches using silver nanoparticles. Pharmaceutics. 2022;14:1463. https:\/\/doi.org\/10.3390\/pharmaceutics14071463.","journal-title":"Pharmaceutics"},{"key":"708_CR131","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3897\/folmed.63.e53479","volume":"63","author":"R Fateh","year":"2021","unstructured":"Fateh R, Javadi A, Kardan-Yamch J, Ali Rahdar H, Amini M, Ghasemi F, Azimi A, Davarpanah M, Mohammadzadeh R. Construction of metronidazole capped in gold nanoparticles against Helicobacter pylori: antimicrobial activity improvement. Folia Med. 2021;63:197\u2013202. https:\/\/doi.org\/10.3897\/folmed.63.e53479.","journal-title":"Folia Med"},{"key":"708_CR132","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12645-022-00121-2","volume":"13","author":"F Meng","year":"2022","unstructured":"Meng F, Tao H, Mi Y, Yang T, Wang X, Go Y, Lin Y, Wang G. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pylori. Cancer Nanotechnol. 2022;13:13. https:\/\/doi.org\/10.1186\/s12645-022-00121-2.","journal-title":"Cancer Nanotechnol"},{"key":"708_CR133","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/md18110542","volume":"18","author":"S-H Chang","year":"2020","unstructured":"Chang S-H, Hsieh P-L, Tsai G-J. Chitosan inhibits Helicobacter pylori growth and urease production and prevents its infection of human gastric carcinoma cells. Mar Drugs. 2020;18:542. https:\/\/doi.org\/10.3390\/md18110542.","journal-title":"Mar Drugs"},{"key":"708_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126706","volume":"253","author":"B Fayed","year":"2023","unstructured":"Fayed B, Jagal J, Cagliani R, Kedia RA, Elsherbeny A, Bayraktutan H, Khoder G, Haider M. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: a novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment. Int J Biol Macromol. 2023;253: 126706. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126706.","journal-title":"Int J Biol Macromol"},{"key":"708_CR135","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1586\/14787210.2014.930663","volume":"12","author":"IC Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves IC, Henriques PC, Seabra CL, Martins MCL. The potential utility of chitosan micro\/nanoparticles in the treatment of gastric infection. Expert Rev Anti Infect Ther. 2014;12:981\u201392. https:\/\/doi.org\/10.1586\/14787210.2014.930663.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"708_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1081271","author":"C Shu","year":"2023","unstructured":"Shu C, Xu Z, He C, Xu X, Zhou Y, Cai B, Zhu Y. Application of biomaterials in the eradication of Helicobacter pylori: a bibliometric analysis and overview. Front Microbiol. 2023. https:\/\/doi.org\/10.3389\/fmicb.2023.1081271.","journal-title":"Front Microbiol"},{"key":"708_CR137","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2120747","author":"Y Lai","year":"2022","unstructured":"Lai Y, Wei W, Du Y, Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microb. 2022. https:\/\/doi.org\/10.1080\/19490976.2022.2120747.","journal-title":"Gut Microb."},{"key":"708_CR138","doi-asserted-by":"publisher","first-page":"106840","DOI":"10.1016\/j.ejps.2024.106840","volume":"200","author":"R Grosso","year":"2024","unstructured":"Grosso R, Benito E, Carbajo-Gordillo AI, D\u00edaz MJ, Garc\u00eda-Mart\u00edn MG. Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization. Eur J Pharm Sci. 2024;200:106840. https:\/\/doi.org\/10.1016\/j.ejps.2024.106840.","journal-title":"Eur J Pharm Sci"},{"key":"708_CR139","doi-asserted-by":"publisher","first-page":"121582","DOI":"10.1016\/j.ijpharm.2022.121582","volume":"617","author":"D Lopes-de-Campos","year":"2022","unstructured":"Lopes-de-Campos D, Leal Seabra C, Pinto RM, Adam S\u0142owi\u0144ski M, Sarmento B, Nunes C, Cristina M, Martins L, Reis S. Targeting and killing the ever-challenging ulcer bug. Int J Pharm. 2022;617:121582. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121582.","journal-title":"Int J Pharm"},{"key":"708_CR140","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2147\/IJN.S193992","volume":"14","author":"D Lopes-de-Campos","year":"2019","unstructured":"Lopes-de-Campos D, Pinto RM, Lima SAC, Santos T, Sarmento B, Nunes C, Reis S. Delivering amoxicillin at the infection site\u2014a rational design through lipid nanoparticles. Int J Nanomed. 2019;14:2781\u201395. https:\/\/doi.org\/10.2147\/IJN.S193992.","journal-title":"Int J Nanomed"},{"key":"708_CR141","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.01.014","volume":"519","author":"CL Seabra","year":"2017","unstructured":"Seabra CL, Nunes C, Gomez-Lazaro M, Correia M, Machado JC, Gon\u00e7alves IC, Reis CA, Reis S, Martins MCL. Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori. Int J Pharm. 2017;519:128\u201337. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.01.014.","journal-title":"Int J Pharm"},{"key":"708_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834934","volume":"12","author":"X Zhu","year":"2022","unstructured":"Zhu X, Su T, Wang S, Zhou H, Shi W. New advances in nano-drug delivery systems: Helicobacter pylori and gastric cancer. Front Oncol. 2022;12: 834934. https:\/\/doi.org\/10.3389\/fonc.2022.834934.","journal-title":"Front Oncol"},{"key":"708_CR143","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2023-0189","author":"A Garg","year":"2024","unstructured":"Garg A, Karhana S, Khan MA. Nanomedicine for the eradication of Helicobacter pylori: recent advances, challenges and future perspective. Fut Microbiol. 2024. https:\/\/doi.org\/10.2217\/fmb-2023-0189.","journal-title":"Fut Microbiol"},{"key":"708_CR144","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/v15020349","volume":"15","author":"MA Elois","year":"2023","unstructured":"Elois MA, da Silva R, Pilati GVT, Rodr\u00edguez-L\u00e1zaro D, Fongaro G. Bacteriophages as biotechnological tools. Viruses. 2023;15:349. https:\/\/doi.org\/10.3390\/v15020349.","journal-title":"Viruses"},{"key":"708_CR145","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/jac\/dku173","volume":"69","author":"TM Viertel","year":"2014","unstructured":"Viertel TM, Ritter K, Horz H-P. Viruses versus bacteria\u2014novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother. 2014;69:2326\u201336. https:\/\/doi.org\/10.1093\/jac\/dku173.","journal-title":"J Antimicrob Chemother"},{"key":"708_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127155","volume":"264","author":"NJ Anyaegbunam","year":"2022","unstructured":"Anyaegbunam NJ, Anekpo CC, Anyaegbunam ZKG, Doowuese Y, Chinaka CB, Odo OJ, Sharndama HC, Okeke OP, Mba IE. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: from research progress to challenges and prospects. Microbiol Res. 2022;264: 127155. https:\/\/doi.org\/10.1016\/j.micres.2022.127155.","journal-title":"Microbiol Res"},{"key":"708_CR147","first-page":"693","volume":"15","author":"M Sabouri Ghannad","year":"2012","unstructured":"Sabouri Ghannad M, Mohammadi A. Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria. Iran J Basic Med Sci. 2012;15:693\u2013701.","journal-title":"Iran J Basic Med Sci"},{"key":"708_CR148","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2217\/fvl.13.58","volume":"8","author":"M Abdel-Haliem","year":"2013","unstructured":"Abdel-Haliem M. Isolation and characterization of bacteriophages of Helicobacter pylori isolated from Egypt. Future Virol. 2013;8:821\u20136. https:\/\/doi.org\/10.2217\/fvl.13.58.","journal-title":"Future Virol"},{"key":"708_CR149","doi-asserted-by":"publisher","first-page":"39235","DOI":"10.1038\/srep39235","volume":"6","author":"FL Nobrega","year":"2016","unstructured":"Nobrega FL, Costa AR, Santos JF, Siliakus MF, Van Lent JW, Kengen SW, Azeredo J, Kluskens LD. Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine. Sci Rep. 2016;6:39235.","journal-title":"Sci Rep"},{"key":"708_CR150","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ph12010043","volume":"12","author":"GK Vinner","year":"2019","unstructured":"Vinner GK, Rezaie-Yazdi Z, Leppanen M, Stapley AGF, Leaper MC, Malik DJ. Microencapsulation of salmonella-specific bacteriophage felix O1 using spray-drying in a pH-responsive formulation and direct compression tableting of powders into a solid oral dosage form. Pharmaceuticals. 2019;12:43. https:\/\/doi.org\/10.3390\/ph12010043.","journal-title":"Pharmaceuticals"},{"key":"708_CR151","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/microorganisms8081214","volume":"8","author":"P Cuomo","year":"2020","unstructured":"Cuomo P, Papaianni M, Fulgione A, Guerra F, Capparelli R, Medaglia C. An innovative approach to control H. pylori-induced persistent inflammation and colonization. Microorganisms. 2020;8:1214. https:\/\/doi.org\/10.3390\/microorganisms8081214.","journal-title":"Microorganisms"},{"key":"708_CR152","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1038\/s41598-017-07278-6","volume":"7","author":"GV Tetz","year":"2017","unstructured":"Tetz GV, Ruggles KV, Zhou H, Heguy A, Tsirigos A, Tetz V. Bacteriophages as potential new mammalian pathogens. Sci Rep. 2017;7:7043. https:\/\/doi.org\/10.1038\/s41598-017-07278-6.","journal-title":"Sci Rep"},{"key":"708_CR153","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3:238\u201350. https:\/\/doi.org\/10.1038\/nrmicro1098.","journal-title":"Nat Rev Microbiol"},{"key":"708_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00194","author":"M Mahlapuu","year":"2016","unstructured":"Mahlapuu M, H\u00e5kansson J, Ringstad L, Bj\u00f6rn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016. https:\/\/doi.org\/10.3389\/fcimb.2016.00194.","journal-title":"Front Cell Infect Microbiol"},{"key":"708_CR155","first-page":"445","volume":"95","author":"IE Mba","year":"2022","unstructured":"Mba IE, Nweze EI. Focus: antimicrobial resistance: antimicrobial peptides therapy: an emerging alternative for treating drug-resistant bacteria. Yale J Biol Med. 2022;95:445.","journal-title":"Yale J Biol Med"},{"key":"708_CR156","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12555","volume":"24","author":"A Neshani","year":"2019","unstructured":"Neshani A, Zare H, Akbari Eidgahi MR, Hooshyar Chichaklu A, Movaqar A, Ghazvini K. Review of antimicrobial peptides with anti-Helicobacter pylori activity. Helicobacter. 2019;24: e12555. https:\/\/doi.org\/10.1111\/hel.12555.","journal-title":"Helicobacter"},{"key":"708_CR157","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jmii.2016.12.005","volume":"50","author":"PY Chung","year":"2017","unstructured":"Chung PY, Khanum R. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect. 2017;50:405\u201310. https:\/\/doi.org\/10.1016\/j.jmii.2016.12.005.","journal-title":"J Microbiol Immunol Infect"},{"key":"708_CR158","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.20.805","author":"A Iwahori","year":"1997","unstructured":"Iwahori A, Hirota Y, Sampe R, Miyano S, Takahashi N, Sasatsu M, Kondo I, Numao N. On the antibacterial activity of normal and reversed magainin 2 analogs against Helicobacter pylori. Biol Pharm Bull. 1997. https:\/\/doi.org\/10.1248\/bpb.20.805.","journal-title":"Biol Pharm Bull"},{"key":"708_CR159","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.peptides.2004.09.012","volume":"26","author":"A Giacometti","year":"2005","unstructured":"Giacometti A, Cirioni O, Ghiselli R, Orlando F, Kamysz W, Rocchi M, D\u2019Amato G, Mocchegiani F, Silvestri C, \u0141ukasiak J, Saba V, Scalise G. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Peptides. 2005;26:207\u201316. https:\/\/doi.org\/10.1016\/j.peptides.2004.09.012.","journal-title":"Peptides"},{"key":"708_CR160","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/md13042287","volume":"13","author":"C-Y Pan","year":"2015","unstructured":"Pan C-Y, Chen J-C, Chen T-L, Wu J-L, Hui C-F, Chen J-Y. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model. Mar Drugs. 2015;13:2287\u2013305. https:\/\/doi.org\/10.3390\/md13042287.","journal-title":"Mar Drugs"},{"key":"708_CR161","doi-asserted-by":"publisher","first-page":"12936","DOI":"10.18632\/oncotarget.4101","volume":"6","author":"JL Narayana","year":"2015","unstructured":"Narayana JL, Huang H-N, Wu C-J, Chen J-Y. Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model. Oncotarget. 2015;6:12936\u201354. https:\/\/doi.org\/10.18632\/oncotarget.4101.","journal-title":"Oncotarget"},{"key":"708_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.09.037","author":"HN Huang","year":"2013","unstructured":"Huang HN, Rajanbabu V, Pan CY, Chan YL, Wu CJ, Chen JY. Jy, Use of the antimicrobial peptide epinecidin-1 to protect against MRSA infection in mice with skin injuries. Biomaterials. 2013. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.09.037.","journal-title":"Biomaterials"},{"key":"708_CR163","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.peptides.2008.10.007","volume":"30","author":"W-J Lin","year":"2009","unstructured":"Lin W-J, Chien Y-L, Pan C-Y, Lin T-L, Chen J-Y, Chiu S-J, Hui C-F. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptides. 2009;30:283\u201390. https:\/\/doi.org\/10.1016\/j.peptides.2008.10.007.","journal-title":"Peptides"},{"key":"708_CR164","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.peptides.2009.08.019","volume":"30","author":"J-Y Chen","year":"2009","unstructured":"Chen J-Y, Lin W-J, Wu J-L, Her GM, Hui C-F. Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells. Peptides. 2009;30:2365\u201373. https:\/\/doi.org\/10.1016\/j.peptides.2009.08.019.","journal-title":"Peptides"},{"key":"708_CR165","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/gt.2012.92","volume":"20","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yu J, Wong CCM, Ling TKW, Li ZJ, Chan KM, Ren SX, Shen J, Chan RLY, Lee CC, Li MSM, Cheng ASL, To KF, Gallo RL, Sung JJY, Wu WKK, Cho CH. Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice. Gene Ther. 2013;20:751\u201360. https:\/\/doi.org\/10.1038\/gt.2012.92.","journal-title":"Gene Ther"},{"key":"708_CR166","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500021","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu WK, Gallo RL, Fang EF, Hu W, Ling TK, Shen J, Chan RL, Lu L, Luo XM, Li MX. Critical role of antimicrobial peptide cathelicidin for controlling Helicobacter pylori survival and infection. J Immunol Baltim Md 1950. 2016. https:\/\/doi.org\/10.4049\/jimmunol.1500021.","journal-title":"J Immunol Baltim Md 1950"},{"key":"708_CR167","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2180-9-187","volume":"9","author":"K Leszczy\u0144ska","year":"2009","unstructured":"Leszczy\u0144ska K, Namiot A, Fein DE, Wen Q, Namiot Z, Savage PB, Diamond S, Janmey PA, Bucki R. Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol. 2009;9:187. https:\/\/doi.org\/10.1186\/1471-2180-9-187.","journal-title":"BMC Microbiol"},{"key":"708_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103847","volume":"138","author":"M Jiang","year":"2020","unstructured":"Jiang M, Ma L, Huang Y, Wu H, Dou J, Zhou C. Antimicrobial activities of peptide Cbf-K16 against drug-resistant Helicobacter pylori infection in vitro and in vivo. Microb Pathog. 2020;138: 103847. https:\/\/doi.org\/10.1016\/j.micpath.2019.103847.","journal-title":"Microb Pathog"},{"key":"708_CR169","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1007\/s00253-018-8982-9","volume":"102","author":"X Zhang","year":"2018","unstructured":"Zhang X, Jiang A, Qi B, Yu H, Xiong Y, Zhou G, Qin M, Dou J, Wang J. Secretion expression of human neutrophil peptide 1 (HNP1) in Pichia pastoris and its functional analysis against antibiotic-resistant Helicobacter pylori. Appl Microbiol Biotechnol. 2018;102:4817\u201327. https:\/\/doi.org\/10.1007\/s00253-018-8982-9.","journal-title":"Appl Microbiol Biotechnol"},{"key":"708_CR170","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/psc.2479","volume":"19","author":"C Avitabile","year":"2013","unstructured":"Avitabile C, Capparelli R, Rigano MM, Fulgione A, Barone A, Pedone C, Romanelli A. Antimicrobial peptides from plants: stabilization of the \u03b3 core of a tomato defensin by intramolecular disulfide bond. J Pept Sci Off Publ Eur Pept Soc. 2013;19:240\u20135. https:\/\/doi.org\/10.1002\/psc.2479.","journal-title":"J Pept Sci Off Publ Eur Pept Soc"},{"key":"708_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10010021","author":"J Guzman","year":"2018","unstructured":"Guzman J, T\u00e9n\u00e9 N, Touchard A, Castillo D, Belkhelfa H, Haddioui-Hbabi L, Treilhou M, Sauvain M. Anti-Helicobacter pylori properties of the ant-venom peptide bicarinalin. Toxins. 2018. https:\/\/doi.org\/10.3390\/toxins10010021.","journal-title":"Toxins"},{"key":"708_CR172","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.peptides.2016.04.001","volume":"79","author":"N T\u00e9n\u00e9","year":"2016","unstructured":"T\u00e9n\u00e9 N, Bonnaf\u00e9 E, Berger F, Rifflet A, Guilhaudis L, S\u00e9galas-Milazzo I, Pipy B, Coste A, Leprince J, Treilhou M. Biochemical and biophysical combined study of bicarinalin, an ant venom antimicrobial peptide. Peptides. 2016;79:103\u201313. https:\/\/doi.org\/10.1016\/j.peptides.2016.04.001.","journal-title":"Peptides"},{"key":"708_CR173","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.peptides.2007.07.007","volume":"28","author":"L Chen","year":"2007","unstructured":"Chen L, Li Y, Li J, Xu X, Lai R, Zou Q. An antimicrobial peptide with antimicrobial activity against Helicobacter pylori. Peptides. 2007;28:1527\u201331. https:\/\/doi.org\/10.1016\/j.peptides.2007.07.007.","journal-title":"Peptides"},{"key":"708_CR174","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00253-017-8302-9","volume":"101","author":"X Zhang","year":"2017","unstructured":"Zhang X, Jiang A, Wang G, Yu H, Qi B, Xiong Y, Zhou G, Qin M, Dou J, Wang J. Fusion expression of the PGLa-AM1 with native structure and evaluation of its anti-Helicobacter pylori activity. Appl Microbiol Biotechnol. 2017;101:5667\u201375. https:\/\/doi.org\/10.1007\/s00253-017-8302-9.","journal-title":"Appl Microbiol Biotechnol"},{"key":"708_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2017.04.004","volume":"138","author":"BO Owolabi","year":"2017","unstructured":"Owolabi BO, Musale V, Ojo OO, Moffett RC, McGahon MK, Curtis TM, Conlon JM, Flatt PR, Abdel-Wahab YHA. Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents. Biochimie. 2017;138:1\u201312. https:\/\/doi.org\/10.1016\/j.biochi.2017.04.004.","journal-title":"Biochimie"},{"key":"708_CR176","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2012.12.116","volume":"431","author":"OO Ojo","year":"2013","unstructured":"Ojo OO, Conlon JM, Flatt PR, Abdel-Wahab YHA. Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells. Biochem Biophys Res Commun. 2013;431:14\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.116.","journal-title":"Biochem Biophys Res Commun"},{"key":"708_CR177","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter PD, Ross RP, Hill C. Bacteriocins\u2014a viable alternative to antibiotics? Nat Rev Microbiol. 2013;11:95\u2013105. https:\/\/doi.org\/10.1038\/nrmicro2937.","journal-title":"Nat Rev Microbiol"},{"key":"708_CR178","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4315\/0362-028x-66.1.3","volume":"66","author":"T-S Kim","year":"2003","unstructured":"Kim T-S, Hur J-W, Yu M-A, Cheigh C-I, Kim K-N, Hwang J-K, Pyun Y-R. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot. 2003;66:3\u201312. https:\/\/doi.org\/10.4315\/0362-028x-66.1.3.","journal-title":"J Food Prot"},{"key":"708_CR179","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nsmb830","volume":"11","author":"S-TD Hsu","year":"2004","unstructured":"Hsu S-TD, Breukink E, Tischenko E, Lutters MAG, de Kruijff B, Kaptein R, Bonvin AMJJ, van Nuland NAJ. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol. 2004;11:963\u20137. https:\/\/doi.org\/10.1038\/nsmb830.","journal-title":"Nat Struct Mol Biol"},{"key":"708_CR180","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1365-2672.2008.04052.x","volume":"106","author":"ED Simova","year":"2009","unstructured":"Simova ED, Beshkova DB, Dimitrov ZP. Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol. 2009;106:692\u2013701. https:\/\/doi.org\/10.1111\/j.1365-2672.2008.04052.x.","journal-title":"J Appl Microbiol"},{"key":"708_CR181","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/molecules27092675","volume":"27","author":"X Li","year":"2022","unstructured":"Li X, Zuo S, Wang B, Zhang K, Wang Y. Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides. Molecules. 2022;27:2675. https:\/\/doi.org\/10.3390\/molecules27092675.","journal-title":"Molecules"},{"key":"708_CR182","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/medsci6020027","volume":"6","author":"V Yurina","year":"2018","unstructured":"Yurina V. Live bacterial vectors\u2014a promising DNA vaccine delivery system. Med Sci. 2018;6:27. https:\/\/doi.org\/10.3390\/medsci6020027.","journal-title":"Med Sci"},{"key":"708_CR183","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/cmi.2017.92","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L. Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cell Mol Immunol. 2018;15:182.","journal-title":"Cell Mol Immunol"},{"key":"708_CR184","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.25.542131","author":"JA Bugaytsova","year":"2023","unstructured":"Bugaytsova JA, Piddubnyi A, Tkachenko I, Rakhimova L, Edlund JO, Thorell K, Marcotte H, Lundquist A, Sch\u00f6n K, Lycke N, Suerbaum S, Schulz C, Malfertheiner P, Hansen LM, Solnick JV, Moskalenko R, Hammarstr\u00f6m L, Bor\u00e9n T. Vaccination with Helicobacter pylori attachment proteins protects against gastric cancer. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.05.25.542131.","journal-title":"bioRxiv"},{"key":"708_CR185","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/femspd\/ftz050","volume":"77","author":"Q Liu","year":"2019","unstructured":"Liu Q, Li X, Zhang Y, Song Z, Li R, Ruan H, Huang X. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice. Pathog Dis. 2019;77:50. https:\/\/doi.org\/10.1093\/femspd\/ftz050.","journal-title":"Pathog Dis"},{"key":"708_CR186","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1038\/s41598-018-24879-x","volume":"8","author":"X Peng","year":"2018","unstructured":"Peng X, Zhang R, Duan G, Wang C, Sun N, Zhang L, Chen S, Fan Q, Xi Y. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Sci Rep. 2018;8:6435. https:\/\/doi.org\/10.1038\/s41598-018-24879-x.","journal-title":"Sci Rep"},{"key":"708_CR187","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.crmicr.2021.100103","volume":"3","author":"M Sharaf","year":"2022","unstructured":"Sharaf M, Arif M, Hamouda HI, Khan S, Abdalla M, Shabana S, Rozan HE, Khan TU, Chi Z, Liu C. Preparation, urease inhibition mechanisms, and anti-Helicobacter pylori activities of hesperetin-7-rhamnoglucoside. Curr Res Microb Sci. 2022;3:100103. https:\/\/doi.org\/10.1016\/j.crmicr.2021.100103.","journal-title":"Curr Res Microb Sci."},{"key":"708_CR188","doi-asserted-by":"publisher","first-page":"49359","DOI":"10.1074\/jbc.M108619200","volume":"276","author":"HK Song","year":"2001","unstructured":"Song HK, Mulrooney SB, Huber R, Hausinger RP. Crystal structure of Klebsiella aerogenesUreE, a nickel-binding metallochaperone for urease activation*. J Biol Chem. 2001;276:49359\u201364. https:\/\/doi.org\/10.1074\/jbc.M108619200.","journal-title":"J Biol Chem"},{"key":"708_CR189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jare.2018.05.010","volume":"13","author":"K Kappaun","year":"2018","unstructured":"Kappaun K, Piovesan AR, Carlini CR, Ligabue-Braun R. Ureases: historical aspects, catalytic, and non-catalytic properties\u2014a review. J Adv Res. 2018;13:3. https:\/\/doi.org\/10.1016\/j.jare.2018.05.010.","journal-title":"J Adv Res"},{"key":"708_CR190","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmgm.2019.07.015","volume":"92","author":"C Pasala","year":"2019","unstructured":"Pasala C, Katari SK, Nalamolu RM, Bitla AR, Amineni U. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains. J Mol Graph Model. 2019;92:167\u201379. https:\/\/doi.org\/10.1016\/j.jmgm.2019.07.015.","journal-title":"J Mol Graph Model"},{"key":"708_CR191","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1038\/s41598-020-65107-9","volume":"10","author":"S Svane","year":"2020","unstructured":"Svane S, Sigurdarson JJ, Finkenwirth F, Eitinger T, Karring H. Inhibition of urease activity by different compounds provides insight into the modulation and association of bacterial nickel import and ureolysis. Sci Rep. 2020;10:8503. https:\/\/doi.org\/10.1038\/s41598-020-65107-9.","journal-title":"Sci Rep"},{"key":"708_CR192","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2174\/1573406416999200818152440","volume":"17","author":"W-W Ni","year":"2021","unstructured":"Ni W-W, Fang H-L, Ye Y-X, Li W-Y, Liu L, Fu Z-J, Dawalamu W-Y, Zhu K, Li F, Li X, Zou H, Ouyang Z-P, Xiao H-L. Synthesis and structure-activity relationship studies of N-monosubstituted aroylthioureas as urease inhibitors. Med Chem. 2021;17:1046\u201359.","journal-title":"Med Chem"},{"key":"708_CR193","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12866-023-02969-9","volume":"23","author":"SM Shafik","year":"2023","unstructured":"Shafik SM, Abbas HA, Yousef N, Saleh MM. Crippling of Klebsiella pneumoniae virulence by metformin, N-acetylcysteine and secnidazole. BMC Microbiol. 2023;23:229. https:\/\/doi.org\/10.1186\/s12866-023-02969-9.","journal-title":"BMC Microbiol"},{"key":"708_CR194","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jare.2014.09.001","volume":"6","author":"LV Modolo","year":"2015","unstructured":"Modolo LV, de Souza AX, Horta LP, Araujo DP, de F\u00e1tima \u00c2. An overview on the potential of natural products as ureases inhibitors: a review. J Adv Res. 2015;6:35\u201344. https:\/\/doi.org\/10.1016\/j.jare.2014.09.001.","journal-title":"J Adv Res"},{"key":"708_CR195","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/molecules18022135","volume":"18","author":"M Amin","year":"2013","unstructured":"Amin M, Anwar F, Naz F, Mehmood T, Saari N. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules. 2013;18:2135\u201349. https:\/\/doi.org\/10.3390\/molecules18022135.","journal-title":"Molecules"},{"key":"708_CR196","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2021.114485.14876","author":"M Eftekhari","year":"2021","unstructured":"Eftekhari M, Shams Ardekani MR, Amin M, Mansourian M, Saeedi M, Akbarzadeh T, Khanavi M. Anti-Helicobacter pylori compounds from Oliveria decumbens Vent. through urease inhibitory in-vitro and in-silico studies, Iran. J Pharm Res. 2021. https:\/\/doi.org\/10.22037\/ijpr.2021.114485.14876.","journal-title":"J Pharm Res"},{"key":"708_CR197","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1080\/14756366.2018.1501044","volume":"33","author":"C Li","year":"2018","unstructured":"Li C, Huang P, Wong K, Xu Y, Tan L, Chen H, Lu Q, Luo C, Tam C, Zhu L, Su Z, Xie J. Coptisine-induced inhibition of Helicobacter pylori\u202f: elucidation of specific mechanisms by probing urease active site and its maturation process. J Enzyme Inhib Med Chem. 2018;33:1362\u201375. https:\/\/doi.org\/10.1080\/14756366.2018.1501044.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"708_CR198","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejps.2017.02.004","volume":"110","author":"L Tan","year":"2017","unstructured":"Tan L, Li C, Chen H, Mo Z, Zhou J, Liu Y, Ma Z, Xu Y, Yang X, Xie J, Su Z. Epiberberine, a natural protoberberine alkaloid, inhibits urease of Helicobacter pylori and jack bean: susceptibility and mechanism. Eur J Pharm Sci. 2017;110:77\u201386. https:\/\/doi.org\/10.1016\/j.ejps.2017.02.004.","journal-title":"Eur J Pharm Sci"},{"key":"708_CR199","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.3390\/ijms22073385","volume":"22","author":"JY Yang","year":"2021","unstructured":"Yang JY, Kim J-B, Lee P, Kim S-H. Evodiamine inhibits Helicobacter pylori growth and Helicobacter pylori-induced inflammation. Int J Mol Sci. 2021;22:3385. https:\/\/doi.org\/10.3390\/ijms22073385.","journal-title":"Int J Mol Sci"},{"key":"708_CR200","doi-asserted-by":"publisher","first-page":"10035","DOI":"10.3390\/ijms221810035","volume":"22","author":"HW Kim","year":"2021","unstructured":"Kim HW, Woo HJ, Yang JY, Kim J-B, Kim S-H. Hesperetin inhibits expression of virulence factors and growth of Helicobacter pylori. Int J Mol Sci. 2021;22:10035. https:\/\/doi.org\/10.3390\/ijms221810035.","journal-title":"Int J Mol Sci"},{"key":"708_CR201","doi-asserted-by":"publisher","first-page":"114578","DOI":"10.1016\/j.jep.2021.114578","volume":"283","author":"J Yan","year":"2022","unstructured":"Yan J, Peng C, Chen P, Zhang W, Jiang C, Sang S, Zhu W, Yuan Y, Hong Y, Yao M. In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch fruit extracts. J Ethnopharmacol. 2022;283:114578. https:\/\/doi.org\/10.1016\/j.jep.2021.114578.","journal-title":"J Ethnopharmacol"},{"key":"708_CR202","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/molecules26092663","volume":"26","author":"HJ Woo","year":"2021","unstructured":"Woo HJ, Yang JY, Lee P, Kim J-B, Kim S-H. Zerumbone inhibits Helicobacter pylori urease activity. Molecules. 2021;26:2663. https:\/\/doi.org\/10.3390\/molecules26092663.","journal-title":"Molecules"},{"key":"708_CR203","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.1021\/jf303393n","volume":"60","author":"Z-P Xiao","year":"2012","unstructured":"Xiao Z-P, Wang X-D, Peng Z-Y, Huang S, Yang P, Li Q-S, Zhou L-H, Hu X-J, Wu L-J, Zhou Y, Zhu H-L. Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. J Agric Food Chem. 2012;60:10572\u20137. https:\/\/doi.org\/10.1021\/jf303393n.","journal-title":"J Agric Food Chem"},{"key":"708_CR204","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/molecules25030586","volume":"25","author":"I Korona-Glowniak","year":"2020","unstructured":"Korona-Glowniak I, Glowniak-Lipa A, Ludwiczuk A, Baj T, Malm A. The in vitro activity of essential oils against Helicobacter pylori growth and urease activity. Molecules. 2020;25:586. https:\/\/doi.org\/10.3390\/molecules25030586.","journal-title":"Molecules"},{"key":"708_CR205","doi-asserted-by":"publisher","first-page":"1464484","DOI":"10.3389\/fmicb.2024.1464484","volume":"15","author":"H Shaalan","year":"2024","unstructured":"Shaalan H, Azrad M, Peretz A. The effect of three urease inhibitors on H. pylori viability, urease activity and urease gene expression. Front Microbiol. 2024;15:1464484. https:\/\/doi.org\/10.3389\/fmicb.2024.1464484.","journal-title":"Front Microbiol"},{"key":"708_CR206","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/bab.1341","volume":"62","author":"HP Borase","year":"2015","unstructured":"Borase HP, Salunkhe RB, Patil CD, Suryawanshi RK, Salunke BK, Wagh ND, Patil SV. Innovative approach for urease inhibition by Ficus carica extract\u2013fabricated silver nanoparticles: an in vitro study. Biotechnol Appl Biochem. 2015;62:780\u20134. https:\/\/doi.org\/10.1002\/bab.1341.","journal-title":"Biotechnol Appl Biochem"},{"key":"708_CR207","doi-asserted-by":"publisher","first-page":"9923","DOI":"10.3390\/ijms13089923","volume":"13","author":"M Amin","year":"2012","unstructured":"Amin M, Anwar F, Janjua MRSA, Iqbal MA, Rashid U. Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. Int J Mol Sci. 2012;13:9923\u201341. https:\/\/doi.org\/10.3390\/ijms13089923.","journal-title":"Int J Mol Sci"},{"key":"708_CR208","doi-asserted-by":"publisher","first-page":"42548","DOI":"10.1021\/acsomega.3c05282","volume":"8","author":"D-M Kang","year":"2023","unstructured":"Kang D-M, Khalil AAK, Park WS, Kim H-J, Akter K-M, Bae J-Y, Mehtap B\u00fcy\u00fcker S, Kim J-H, Kang KK, Ahn M-J. Anti-Helicobacter pylori activity of six major compounds isolated from Rumex acetosa. ACS Omega. 2023;8:42548\u201354. https:\/\/doi.org\/10.1021\/acsomega.3c05282.","journal-title":"ACS Omega"},{"key":"708_CR209","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3390\/life13071512","volume":"13","author":"AMH Al-Rajhi","year":"2023","unstructured":"Al-Rajhi AMH, Qanash H, Almashjary MN, Hazzazi MS, Felemban HR, Abdelghany TM. Anti-Helicobacter pylori, antioxidant, antidiabetic, and anti-Alzheimer\u2019s activities of laurel leaf extract treated by moist heat and molecular docking of its flavonoid constituent, naringenin, against acetylcholinesterase and butyrylcholinesterase. Life. 2023;13:1512. https:\/\/doi.org\/10.3390\/life13071512.","journal-title":"Life"},{"key":"708_CR210","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1080\/14786419.2022.2110096","volume":"37","author":"N Chelleng","year":"2023","unstructured":"Chelleng N, Puzari M, Chetia P, Tamuly C. Phenolic compounds of Zanthoxylum armatum DC as potential inhibitors of urease and SARS-CoV2 using molecular docking approach and with simulation study. Nat Prod Res. 2023;37:1993\u20137. https:\/\/doi.org\/10.1080\/14786419.2022.2110096.","journal-title":"Nat Prod Res"},{"key":"708_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25232","volume":"10","author":"HS Mohammed","year":"2024","unstructured":"Mohammed HS, Ibrahim MH, Abdel-Aziz MM, Ghareeb MA. Anti-Helicobacter pylori, anti-biofilm activity, and molecular docking study of citropten, bergapten, and its positional isomer isolated from Citrus sinensis L. leaves. Heliyon. 2024;10: e25232. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25232.","journal-title":"Heliyon."},{"key":"708_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133735","volume":"276","author":"MA Haq","year":"2024","unstructured":"Haq MA, Nazir M, Jabeen G, Jabeen N, Naz S, Nawaz H, Xu J. Inhibitory effect of polyphenols from sumac, pomegranate and Indian almond on urease producing bacteria and jack bean urease activity. Int J Biol Macromol. 2024;276: 133735. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133735.","journal-title":"Int J Biol Macromol"},{"key":"708_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2013.03.126","volume":"435","author":"JW Fahey","year":"2013","unstructured":"Fahey JW, Stephenson KK, Wade KL, Talalay P. Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates. Biochem Biophys Res Commun. 2013;435:1\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2013.03.126.","journal-title":"Biochem Biophys Res Commun"},{"key":"708_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-019-0562-2","author":"R Kataria","year":"2019","unstructured":"Kataria R. Molecular docking, synthesis, kinetics study, structure\u2013activity relationship and ADMET analysis of morin analogous as Helicobacter pylori urease inhibitors. BMC Chem. 2019. https:\/\/doi.org\/10.1186\/s13065-019-0562-2.","journal-title":"BMC Chem"},{"key":"708_CR215","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/molecules25061352","volume":"25","author":"T Fan","year":"2020","unstructured":"Fan T, Guo X, Zeng Q, Wei W, You X, Pang J, Wang Y, Song D. Synthesis and Structure-activity relationship of palmatine derivatives as a novel class of antibacterial agents against Helicobacter pylori. Molecules. 2020;25:1352. https:\/\/doi.org\/10.3390\/molecules25061352.","journal-title":"Molecules"},{"key":"708_CR216","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejmech.2013.03.016","volume":"63","author":"Z-P Xiao","year":"2013","unstructured":"Xiao Z-P, Peng Z-Y, Dong J-J, He J, Ouyang H, Feng Y-T, Lu C-L, Lin W-Q, Wang J-X, Xiang Y-P, Zhu H-L. Synthesis, structure\u2013activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors. Eur J Med Chem. 2013;63:685\u201395. https:\/\/doi.org\/10.1016\/j.ejmech.2013.03.016.","journal-title":"Eur J Med Chem"},{"key":"708_CR217","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.3390\/molecules26237150","volume":"26","author":"A Ahmed","year":"2021","unstructured":"Ahmed A, Saeed A, Ali OM, El-Bahy ZM, Channar PA, Khurshid A, Tehzeeb A, Ashraf Z, Raza H, Ul-Hamid A, Hassan M. Exploring amantadine derivatives as urease inhibitors: molecular docking and structure-activity relationship (SAR) studies. Molecules. 2021;26:7150. https:\/\/doi.org\/10.3390\/molecules26237150.","journal-title":"Molecules"},{"key":"708_CR218","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1080\/07391102.2018.1546620","volume":"37","author":"R Arora","year":"2019","unstructured":"Arora R, Issar U, Kakkar R. Identification of novel urease inhibitors: pharmacophore modeling, virtual screening and molecular docking studies. J Biomol Struct Dyn. 2019;37:4312\u201326. https:\/\/doi.org\/10.1080\/07391102.2018.1546620.","journal-title":"J Biomol Struct Dyn"},{"key":"708_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103479","volume":"95","author":"A Ibrar","year":"2020","unstructured":"Ibrar A, Kazmi M, Khan A, Halim SA, Saeed A, Mehsud S, Al-Harrasi A, Khan I. Robust therapeutic potential of carbazole-triazine hybrids as a new class of urease inhibitors: a distinctive combination of nitrogen-containing heterocycles. Bioorganic Chem. 2020;95: 103479. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103479.","journal-title":"Bioorganic Chem"},{"key":"708_CR220","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1039\/D0RA02363A","volume":"10","author":"M Imran","year":"2020","unstructured":"Imran M, Waqar S, Ogata K, Ahmed M, Noreen Z, Javed S, Bibi N, Bokhari H, Amjad A, Muddassar M. Identification of novel bacterial urease inhibitors through molecular shape and structure based virtual screening approaches. RSC Adv. 2020;10:16061\u201370. https:\/\/doi.org\/10.1039\/D0RA02363A.","journal-title":"RSC Adv"},{"key":"708_CR221","doi-asserted-by":"publisher","first-page":"10607","DOI":"10.1038\/s41598-021-90104-x","volume":"11","author":"K Pedrood","year":"2021","unstructured":"Pedrood K, Azizian H, Montazer MN, Mohammadi-Khanaposhtani M, Asgari MS, Asadi M, Bahadorikhalili S, Rastegar H, Larijani B, Amanlou M, Mahdavi M. Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors. Sci Rep. 2021;11:10607. https:\/\/doi.org\/10.1038\/s41598-021-90104-x.","journal-title":"Sci Rep"},{"key":"708_CR222","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bioorg.2015.12.007","volume":"64","author":"A Khan","year":"2016","unstructured":"Khan A, Hashim J, Arshad N, Khan I, Siddiqui N, Wadood A, Ali M, Arshad F, Khan KM, Choudhary MI. Dihydropyrimidine based hydrazine dihydrochloride derivatives as potent urease inhibitors. Bioorg Chem. 2016;64:85\u201396. https:\/\/doi.org\/10.1016\/j.bioorg.2015.12.007.","journal-title":"Bioorg Chem"},{"key":"708_CR223","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s00894-011-1310-2","volume":"18","author":"H Azizian","year":"2012","unstructured":"Azizian H, Nabati F, Sharifi A, Siavoshi F, Mahdavi M, Amanlou M. Large-scale virtual screening for the identification of new Helicobacter pylori urease inhibitor scaffolds. J Mol Model. 2012;18:2917\u201327. https:\/\/doi.org\/10.1007\/s00894-011-1310-2.","journal-title":"J Mol Model"},{"key":"708_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103529","volume":"95","author":"M Biglar","year":"2020","unstructured":"Biglar M, Mirzazadeh R, Asadi M, Sepehri S, Valizadeh Y, Sarrafi Y, Amanlou M, Larijani B, Mohammadi-Khanaposhtani M, Mahdavi M. Novel N, N-dimethylbarbituric-pyridinium derivatives as potent urease inhibitors: synthesis, in vitro, and in silico studies. Bioorg Chem. 2020;95: 103529. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103529.","journal-title":"Bioorg Chem"},{"key":"708_CR225","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/14756366.2011.599065","volume":"27","author":"Y-M Cui","year":"2012","unstructured":"Cui Y-M, Dong X-W, Chen W, Wang W-J, Li Y-G, Zhu H-L. Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease. J Enzyme Inhib Med Chem. 2012;27:528\u201332. https:\/\/doi.org\/10.3109\/14756366.2011.599065.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"708_CR226","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jinorgbio.2016.02.017","volume":"159","author":"L Pan","year":"2016","unstructured":"Pan L, Wang C, Yan K, Zhao K, Sheng G, Zhu H, Zhao X, Qu D, Niu F, You Z. Synthesis, structures and Helicobacter pylori urease inhibitory activity of copper(II) complexes with tridentate aroylhydrazone ligands. J Inorg Biochem. 2016;159:22\u20138. https:\/\/doi.org\/10.1016\/j.jinorgbio.2016.02.017.","journal-title":"J Inorg Biochem"},{"key":"708_CR227","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bmc.2015.12.013","volume":"24","author":"C Jing","year":"2016","unstructured":"Jing C, Wang C, Yan K, Zhao K, Sheng G, Qu D, Niu F, Zhu H, You Z. Synthesis, structures and urease inhibitory activity of cobalt(III) complexes with Schiff bases. Bioorg Med Chem. 2016;24:270\u20136. https:\/\/doi.org\/10.1016\/j.bmc.2015.12.013.","journal-title":"Bioorg Med Chem"},{"key":"708_CR228","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejmech.2018.06.065","volume":"156","author":"Q Liu","year":"2018","unstructured":"Liu Q, Shi W-K, Ren S-Z, Ni W-W, Li W-Y, Chen H-M, Liu P, Yuan J, He X-S, Liu J-J, Cao P, Yang P-Z, Xiao Z-P, Zhu H-L. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur J Med Chem. 2018;156:126\u201336. https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.065.","journal-title":"Eur J Med Chem"},{"key":"708_CR229","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286684","volume":"18","author":"AI Shahin","year":"2023","unstructured":"Shahin AI, Zaib S, Zaraei S-O, Kedia RA, Anbar HS, Younas MT, Al-Tel TH, Khoder G, El-Gamal MI. Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori. PLoS ONE. 2023;18: e0286684. https:\/\/doi.org\/10.1371\/journal.pone.0286684.","journal-title":"PLoS ONE"},{"key":"708_CR230","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/molecules27030865","volume":"27","author":"SO Mohammed","year":"2022","unstructured":"Mohammed SO, El Ashry SHE, Khalid A, Amer MR, Metwaly AM, Eissa IH, Elkaeed EB, Elshobaky A, Hafez EE. Expression, purification, and comparative inhibition of Helicobacter pylori urease by regio-selectively alkylated benzimidazole 2-thione derivatives. Molecules. 2022;27:865. https:\/\/doi.org\/10.3390\/molecules27030865.","journal-title":"Molecules"},{"key":"708_CR231","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100465RR","volume":"35","author":"F Liu","year":"2021","unstructured":"Liu F, Yu J, Zhang Y-X, Li F, Liu Q, Zhou Y, Huang S, Fang H, Xiao Z, Liao L, Xu J, Wu X-Y, Wu F. High-throughput tandem-microwell assay for ammonia repositions FDA-approved drugs to inhibit Helicobacter pylori urease. FASEB J. 2021;35: e21967. https:\/\/doi.org\/10.1096\/fj.202100465RR.","journal-title":"FASEB J"},{"key":"708_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106275","volume":"130","author":"S-Y Li","year":"2023","unstructured":"Li S-Y, Zhang Y, Wang Y-N, Yuan L-C, Kong C-C, Xiao Z-P, Zhu H-L. Identification of (N-aryl-N-arylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors and the mechanism exploration. Bioorg Chem. 2023;130: 106275. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106275.","journal-title":"Bioorg Chem"},{"key":"708_CR233","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/14756366.2019.1706503","volume":"35","author":"W-Y Li","year":"2020","unstructured":"Li W-Y, Ni W-W, Ye Y-X, Fang H-L, Pan X-M, He J-L, Zhou T-L, Yi J, Liu S-S, Zhou M, Xiao Z-P, Zhu H-L. N -monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation. J Enzym Inhib Med Chem. 2020;35:404\u201313. https:\/\/doi.org\/10.1080\/14756366.2019.1706503.","journal-title":"J Enzym Inhib Med Chem"},{"key":"708_CR234","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1039\/C5DT05061H","volume":"45","author":"DM Keogan","year":"2016","unstructured":"Keogan DM, Twamley B, Fitzgerald-Hughes D, Griffith DM. Novel class of Bi( III ) hydroxamato complexes: synthesis, urease inhibitory activity and activity against H. pylori. Dalton Trans. 2016;45:11008\u201314. https:\/\/doi.org\/10.1039\/C5DT05061H.","journal-title":"Dalton Trans"},{"key":"708_CR235","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bioorg.2018.04.007","volume":"78","author":"M Taha","year":"2018","unstructured":"Taha M, Wadood A. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors. Bioorganic Chem. 2018;78:411\u20137. https:\/\/doi.org\/10.1016\/j.bioorg.2018.04.007.","journal-title":"Bioorganic Chem"},{"key":"708_CR236","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1038\/s41598-019-43082-0","volume":"9","author":"F Rizvi","year":"2019","unstructured":"Rizvi F, Khan M, Jabeen A, Siddiqui H, Choudhary MI. Studies on isoniazid derivatives through a medicinal chemistry approach for the identification of new inhibitors of urease and inflammatory markers. Sci Rep. 2019;9:6738. https:\/\/doi.org\/10.1038\/s41598-019-43082-0.","journal-title":"Sci Rep"},{"key":"708_CR237","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bioorg.2015.10.005","volume":"63","author":"F Rahim","year":"2015","unstructured":"Rahim F, Zaman K, Ullah H, Taha M, Wadood A, Javed MT, Rehman W, Ashraf M, Uddin R, Uddin I, Asghar H, Khan AA, Khan KM. Synthesis of 4-thiazolidinone analogs as potent in vitro anti-urease agents. Bioorg Chem. 2015;63:123\u201331. https:\/\/doi.org\/10.1016\/j.bioorg.2015.10.005.","journal-title":"Bioorg Chem"},{"key":"708_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-015-0140-1","author":"A Barakat","year":"2015","unstructured":"Barakat A. Synthesis and dynamics studies of barbituric acid derivatives as urease inhibitors. Chem Central J. 2015. https:\/\/doi.org\/10.1186\/s13065-015-0140-1.","journal-title":"Chem Central J"},{"key":"708_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115528","volume":"257","author":"M Ma\u015blanka","year":"2023","unstructured":"Ma\u015blanka M, Tabor W, Krzy\u017cek P, Grabowiecka A, Berlicki \u0141, Mucha A. Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis. Eur J Med Chem. 2023;257: 115528. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115528.","journal-title":"Eur J Med Chem"},{"key":"708_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132502","volume":"271","author":"O Hashem","year":"2024","unstructured":"Hashem O, Zaib S, Zaraei S-O, Javed H, Kedia RA, Anbar HS, Khan I, Ravi A, El-Gamal MI, Khoder G. Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran\/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections. Int J Biol Macromol. 2024;271: 132502. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.132502.","journal-title":"Int J Biol Macromol"},{"key":"708_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105545","volume":"119","author":"S Zaib","year":"2022","unstructured":"Zaib S, Tayyab Younas M, Zaraei S-O, Khan I, Anbar HS, El-Gamal MI. Discovery of urease inhibitory effect of sulfamate derivatives: biological and computational studies. Bioorg Chem. 2022;119: 105545. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105545.","journal-title":"Bioorg Chem"},{"key":"708_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136361","volume":"281","author":"Y Khan","year":"2024","unstructured":"Khan Y, Solangi M, Khan KM, Ullah N, Iqbal J, Hussain Z, Khan IA, Salar U, Taha M. Exploration of thiazine Schiff bases as promising urease inhibitors: design, synthesis, enzyme inhibition, kinetic analysis, ADME\/T evaluation, and molecular docking studies. Int J Biol Macromol. 2024;281: 136361. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136361.","journal-title":"Int J Biol Macromol"},{"key":"708_CR243","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijbiomac.2021.12.064","volume":"198","author":"U Zahra","year":"2022","unstructured":"Zahra U, Zaib S, Saeed A, Rehman MU, Shabir G, Alsaab HO, Khan I. New acetylphenol-based acyl thioureas broaden the scope of drug candidates for urease inhibition: synthesis, in vitro screening and in silico analysis. Int J Biol Macromol. 2022;198:157\u201367. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.064.","journal-title":"Int J Biol Macromol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00708-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:36:04Z","timestamp":1748428564000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":243,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00708-1","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}